Also listed on Universite de Montpellier, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Feb 15, 2028 · High confidence
20-year base term ends Dec 27, 2027
Held by Idenix Pharmaceuticals, Inc., Centre National de la Recherche Scientifique and Universite Montpellier II
Filed Dec 27, 2007 as application 12/005,937 · Granted May 31, 2011
Base term plus 50 days of patent term adjustment (USPTO delay)
Today
2007
2028
Clock starts
Dec 27, 2007
Dec 27, 2007
Term ends
Feb 15, 2028
Feb 15, 2028
Granted
May 31, 2011
May 31, 2011
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
50
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
52
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 50 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 27, 2007, when this application, 12/005,937, was filed | Dec 27, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +50 days, USPTO patent term adjustment record | Feb 15, 2028 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 15, 2028 | High confidence |
This family
| US 6,596,700 | Lapsed on the fee record Jul 2011 | Jul 2011 |
| US 6,566,344 | Term ended Aug 2019 | Aug 2019 |
| US 6,569,837 | Term ended no later than Oct 2020 | no later than Oct 2020 |
| US 6,787,526 | Lapsed on the fee record Sep 2012 | Sep 2012 |
| US 6,946,450 | Term ended Aug 2019 | Aug 2019 |
| US 7,608,600 | In force no later than Sep 2028 | no later than Sep 2028 |
| US 7,662,798 | Lapsed on the fee record Feb 2022 | Feb 2022 |
| Application 11/005,440 | Abandoned not computed | not computed |
8 of 52 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 27, 2008 Reel 21160, frame 41 | Peyrottes, Suzanne; Gosselin, Gilles | Centre National de la Recherche Scientifique | Assignment of Assignor's Interest |
| Jun 27, 2008 Reel 21160, frame 88 | Perigaud, Christian | L'Universite Montpellier II | Assignment of Assignor's Interest |
| Jun 27, 2008 Reel 21159, frame 946 | Pierra, Claire; Sommadossi, Jean-pierre | Idenix Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jun 9, 2011 reel/frame not recorded | Centre National de la Recherche Scientifique; Idenix (Cayman) Limited; Idenix Pharmaceuticals, Inc.; Idenix SARL; Universite Montpellier II | Idenix Pharmaceuticals, Inc. | Patent Assignment Agreement |
| Jun 9, 2011 reel/frame not recorded | Centre National de la Recherche Scientifique; Idenix (Cayman) Limited; Idenix Pharmaceuticals, Inc.; Idenix SARL; Universite Montpellier II | Centre National de la Recherche Scientifique | Patent Assignment Agreement |
| Jun 9, 2011 reel/frame not recorded | Centre National de la Recherche Scientifique; Idenix (Cayman) Limited; Idenix Pharmaceuticals, Inc.; Idenix SARL; Universite Montpellier II | Universite Montpellier II | Patent Assignment Agreement |
| Jun 9, 2011 Reel 26417, frame 361 | Idenix Pharmaceuticals, Inc.; Idenix SARL; Idenix (Cayman) Limited; Centre National de la Recherche Scientifique; Universite Montpellier II | Idenix Pharmaceuticals, Inc.; Centre National de la Recherche Scientifique; Universite Montpellier II | Patent Assignment Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2028
Term ends Feb 15, 2028. No further fees fall due before then
Note
The 50 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
70
later US patents cite this one
That is top 10% of utility patents granted in 2011 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.